An In Silico and In vitro Study Examining the Links between T-Cells, MicroRNA, and mRNA Targets/Pathways Associated...

Area of Science:

• Immunology
• Genomics
• Molecular Biology

Background:

• Acquired aplastic anemia (AA) is characterized by T-cell dysregulation.
• Understanding the molecular underpinnings of T-cell dysfunction in AA is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the differential expression of microRNAs (miRNAs) and messenger RNAs (mRNAs) in T cells from AA patients compared to healthy controls.
• To identify key miRNA-mRNA interactions and signaling pathways involved in the pathobiology of AA.

Main Methods:

• Utilized publicly available miRNA (GSE82095) and mRNA (GSE3807) datasets from T cells of AA patients and controls.
• Performed differential expression analysis, miRNA enrichment analysis, target prediction, and functional enrichment analysis (GSEA).
• Conducted network analysis to identify hub genes and key signaling pathways.

Main Results:

• Identified 41 differentially expressed miRNAs and 944 mRNA targets in T cells of AA patients.
• Network analysis highlighted 10 key pathways, including Interleukin-13, PI3K-Akt, and MAPK signaling.
• Identified 10 hub genes and common transcription factors involved in AA pathogenesis.

Conclusions:

• Significant miRNA-mRNA regulatory networks are implicated in the immune pathogenesis of acquired AA.
• Key pathways and hub genes identified may serve as potential diagnostic biomarkers or therapeutic targets for AA.
• Further experimental validation is warranted to confirm the clinical significance of these findings.